Exagen Featured in Eight Scientific Presentations at The 2018 ACR/ARHP Annual Meeting in Chicago, IL
October 02, 2018 08:47 ET
|
Exagen Diagnostics, Inc.
ALBUQUERQUE, NM and SAN DIEGO, CA, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, the exclusive providers of AVISE® testing, announced today that a total of eight scientific presentations...
Exagen, Maker of AVISE Testing, Announces First Blood Test for Anti-CarP, a Breakthrough Bio-marker for Rheumatoid Arthritis
September 11, 2018 10:05 ET
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, the leader in specialty rheumatology testing, announced today availability of the first validated blood test...
Exagen Diagnostics Announces Evidence Development Agreement with a Large Mid-Atlantic Health Insurer for the AVISE® Lupus Test
August 20, 2018 11:20 ET
|
Exagen Diagnostics, Inc.
Albuquerque and San Diego, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics Announces Evidence Development Agreement with a Large Mid-Atlantic Health Insurer for the AVISE® Lupus Test, see full...
Exagen Diagnostics Closes Series F Equity and Debt Raise Totaling $48 Million
September 11, 2017 08:58 ET
|
Exagen Diagnostics, Inc.
ALBUQUERQUE, NM and SAN DIEGO, CA, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Exagen Diagnostics Inc. (“Exagen”), a commercial stage specialty diagnostic company and exclusive home of AVISE testing,...
Improved Laboratory Testing with EC4d Can Help Physicians Monitor Patients with Lupus
June 12, 2017 07:43 ET
|
Exagen Diagnostics, Inc.
ALBUQUERQUE, NM and SAN DIEGO, CA, June 12, 2017 (GLOBE NEWSWIRE) -- Exagen Diagnostics, Inc., home of AVISE® testing, announced the nationwide availability of a new test leveraging the power of...